{
      "brief_title": [
            "study",
            "ass",
            "capecitabine",
            "patient",
            "locally",
            "advance",
            "metastatic",
            "breast",
            "cancer"
      ],
      "brief_summary": [
            "2",
            "arm",
            "study",
            "compare",
            "efficacy",
            "safety",
            "label",
            "dose",
            "capecitabine",
            "lower",
            "dose",
            "plus",
            "docetaxel",
            "patient",
            "locally",
            "advance",
            "metastatic",
            "breast",
            "cancer",
            "failure",
            "chemotherapy",
            "anthracycline",
            "patient",
            "randomize",
            "receive",
            "either",
            "1250",
            "825",
            "orally",
            "twice",
            "day",
            "po",
            "bid",
            "day",
            "3",
            "week",
            "cycle",
            "combination",
            "75",
            "intravenous",
            "iv",
            "day",
            "1",
            "3",
            "week",
            "cycle",
            "anticipate",
            "time",
            "study",
            "treatment",
            "disease",
            "progression",
            "target",
            "sample",
            "size",
            "440",
            "individual"
      ],
      "condition": [
            "cancer"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "capecitabine (Xeloda\u00ae)",
            "docetaxel (Taxotere\u00ae)"
      ],
      "description": [
            "1250",
            "orally",
            "twice",
            "day",
            "day",
            "1",
            "14",
            "3",
            "week",
            "cycle",
            "intravenous",
            "day",
            "1",
            "3",
            "week",
            "cycle"
      ],
      "arm_group_label": [
            "capecitabine",
            "docetaxel",
            "capecitabine",
            "docetaxel",
            "capecitabine",
            "docetaxel",
            "capecitabine",
            "docetaxel"
      ],
      "other_name": [],
      "criteria": [
            "inclusion",
            "criterion",
            "woman",
            "year",
            "age",
            "target",
            "lesion",
            "locally",
            "advance",
            "metastatic",
            "breast",
            "cancer",
            "demonstrate",
            "resistance",
            "anthracycline",
            "regimen",
            "chemotherapy",
            "disease",
            "exclusion",
            "criterion",
            "previous",
            "treatment",
            "xeloda",
            "continuous",
            "infusion",
            "oral",
            "fluoropyrimidines",
            "previous",
            "treatment",
            "paclitaxel",
            "docetaxel",
            "disease"
      ],
      "gender": "Female",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "neoplasm"
      ],
      "id": "NCT00077857"
}